2025-04-01 2026-03-31 false No description of principal activity Capium Accounts Production 1.1 15547843 2025-04-01 2026-03-31 15547843 bus:AbridgedAccounts 2025-04-01 2026-03-31 15547843 bus:Micro-entities 2025-04-01 2026-03-31 15547843 bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 15547843 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 15547843 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 15547843 2025-04-01 2026-03-31 15547843 2026-03-31 15547843 bus:RegisteredOffice 2025-04-01 2026-03-31 15547843 core:WithinOneYear 2026-03-31 15547843 core:AfterOneYear 2026-03-31 15547843 1 2025-04-01 2026-03-31 15547843 bus:Director1 2025-04-01 2026-03-31 15547843 bus:Director1 2026-03-31 15547843 bus:Director1 2024-03-08 2025-03-31 15547843 2024-03-08 15547843 bus:LeadAgentIfApplicable 2025-04-01 2026-03-31 15547843 2024-03-08 2025-03-31 15547843 2025-03-31 15547843 core:WithinOneYear 2025-03-31 15547843 core:AfterOneYear 2025-03-31 15547843 bus:EntityAccountantsOrAuditors 2024-03-08 2025-03-31 15547843 bus:OrdinaryShareClass1 2025-04-01 2026-03-31 15547843 bus:OrdinaryShareClass1 2026-03-31 15547843 bus:OrdinaryShareClass1 2024-03-08 2025-03-31 15547843 bus:OrdinaryShareClass1 2025-03-31 15547843 core:CostValuation core:Non-currentFinancialInstruments 2026-03-31 15547843 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 15547843 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-03-31 15547843 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-03-31 15547843 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-03-31 15547843 core:Non-currentFinancialInstruments 2026-03-31 15547843 core:Non-currentFinancialInstruments 2025-03-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 15547843
England and Wales

 

 

 

REN THERAPEUTICS LTD



Abridged Accounts
 


Period of accounts

Start date: 01 April 2025

End date: 31 March 2026
  2026   2025
    £ £   £ £
Current assets 312      7,993   
Creditors: amount falling due within one year (2,215)     (8,500)  
Net current assets   (1,903)     (507)
Total assets less current liabilities   (1,903)     (507)
Net assets   (1,903)     (507)
 

         
Capital and reserves   (1,903)     (507)
 
NOTES TO THE ACCOUNTS

General Information
REN THERAPEUTICS LTD is a private company, limited by shares, registered in England and Wales, registration number 15547843, registration address 15 HEATH PARK COURT, ROMFORD ENGLAND, RM2 5UA.

The presentation currency is £ sterling.
1.

Accounting policies

Going concern basis
The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.
2.

Average number of employees

Average number of employees during the year was 0 (2025 : 0).


For the year ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts.
The financial statements were approved by the director on 05 August 2026 and were signed by:


--------------------------------
Sowmya RENIKINDI
Director
1